404 related articles for article (PubMed ID: 30429352)
21. [Establishment of a Model of Infection by Enterovirus 71 in ICR Mice].
Dong Z; Zhang Z; Yang L; Li D; Shi W
Bing Du Xue Bao; 2016 Nov; 32(6):671-82. PubMed ID: 30004196
[TBL] [Abstract][Full Text] [Related]
22. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
23. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
J Virol; 2019 May; 93(10):. PubMed ID: 30867299
[TBL] [Abstract][Full Text] [Related]
24. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
25. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R
J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926
[TBL] [Abstract][Full Text] [Related]
26. Enterovirus A71 crosses a human blood-brain barrier model through infected immune cells.
Gaume L; Chabrolles H; Bisseux M; Lopez-Coqueiro I; Dehouck L; Mirand A; Henquell C; Gosselet F; Archimbaud C; Bailly J-L
Microbiol Spectr; 2024 Jun; 12(6):e0069024. PubMed ID: 38752731
[TBL] [Abstract][Full Text] [Related]
27. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
[No Abstract] [Full Text] [Related]
28. Establishment of Asia-Pacific Network for Enterovirus Surveillance.
Chiu ML; Luo ST; Chen YY; Chung WY; Duong V; Dussart P; Chan YF; Perera D; Ooi MH; Thao NTT; Truong HK; Lee MS
Vaccine; 2020 Jan; 38(1):1-9. PubMed ID: 31679864
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection.
Xing J; Wang K; Wang G; Li N; Zhang Y
Arch Virol; 2022 Dec; 167(12):2483-2501. PubMed ID: 36171507
[TBL] [Abstract][Full Text] [Related]
30. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 May; 91(9):. PubMed ID: 28250116
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary and central nervous system pathology in fatal cases of hand foot and mouth disease caused by enterovirus A71 infection.
Wang Z; Nicholls JM; Liu F; Wang J; Feng Z; Liu D; Sun Y; Zhou C; Li Y; Li H; Qi S; Huang X; Sui J; Liao Q; Peiris M; Yu H; Wang Y
Pathology; 2016 Apr; 48(3):267-74. PubMed ID: 27020504
[TBL] [Abstract][Full Text] [Related]
32. Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses.
Lin YW; Wang LC; Lee CK; Chen SH
Sci Rep; 2018 Aug; 8(1):12184. PubMed ID: 30111869
[TBL] [Abstract][Full Text] [Related]
33. Lipidomic Profiling Reveals Significant Perturbations of Intracellular Lipid Homeostasis in Enterovirus-Infected Cells.
Yan B; Zou Z; Chu H; Chan G; Tsang JO; Lai PM; Yuan S; Yip CC; Yin F; Kao RY; Sze KH; Lau SK; Chan JF; Yuen KY
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779252
[TBL] [Abstract][Full Text] [Related]
34. [Role of Toll-like receptor 7 in the production of inflammatory cytokines in EV-A71-infected human Jurkat T cells].
Chi J; He Y; Yu G; Lei L
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):266-9. PubMed ID: 26957247
[TBL] [Abstract][Full Text] [Related]
35. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of enterovirus-A71 in children with acute flaccid paralysis in the Philippines.
Apostol LN; Shimizu H; Suzuki A; Umami RN; Jiao MMA; Tandoc A; Saito M; Lupisan S; Oshitani H
BMC Infect Dis; 2019 May; 19(1):370. PubMed ID: 31046684
[TBL] [Abstract][Full Text] [Related]
37. Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses.
Ong KC; Wong KT
Brain Pathol; 2015 Sep; 25(5):614-24. PubMed ID: 26276025
[TBL] [Abstract][Full Text] [Related]
38. An auto-antibody identified from phenotypic directed screening platform shows host immunity against EV-A71 infection.
Cheng YW; Chuang YC; Huang SW; Liu CC; Wang JR
J Biomed Sci; 2022 Feb; 29(1):10. PubMed ID: 35130884
[TBL] [Abstract][Full Text] [Related]
39. The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother-neonate cohort study.
Wei X; Yang J; Gao L; Wang L; Liao Q; Qiu Q; Luo K; Yu S; Zhou Y; Liu F; Chen Q; Zhang J; Dai B; Yang H; Zhou J; Xing W; Chen X; He M; Ren L; Guo J; Luo L; Wu P; Chen Z; van Doorn HR; Cauchemez S; Cowling BJ; Yu H
Lancet Infect Dis; 2021 Mar; 21(3):418-426. PubMed ID: 33031750
[TBL] [Abstract][Full Text] [Related]
40. A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge.
Lin YL; Cheng PY; Chin CL; Chuang KT; Lin JY; Chang N; Pan CK; Lin CS; Pan SC; Chiang BL
J Biomed Sci; 2023 Dec; 30(1):96. PubMed ID: 38110940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
